DE602005016648D1 - Metallkomplexe mit vitamin b12 als ligand - Google Patents

Metallkomplexe mit vitamin b12 als ligand

Info

Publication number
DE602005016648D1
DE602005016648D1 DE602005016648T DE602005016648T DE602005016648D1 DE 602005016648 D1 DE602005016648 D1 DE 602005016648D1 DE 602005016648 T DE602005016648 T DE 602005016648T DE 602005016648 T DE602005016648 T DE 602005016648T DE 602005016648 D1 DE602005016648 D1 DE 602005016648D1
Authority
DE
Germany
Prior art keywords
vitamin
ligand
metal complexes
cyanide
complex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005016648T
Other languages
English (en)
Inventor
Roger Alberto
Castro Hector Humberto Knight
Stefan Mundwiler
Susanne Barbara Kunze
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universitaet Zuerich
Original Assignee
Universitaet Zuerich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universitaet Zuerich filed Critical Universitaet Zuerich
Publication of DE602005016648D1 publication Critical patent/DE602005016648D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F19/00—Metal compounds according to more than one of main groups C07F1/00 - C07F17/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds
    • A61K47/551—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds one of the codrug's components being a vitamin, e.g. niacinamide, vitamin B3, cobalamin, vitamin B12, folate, vitamin A or retinoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0453—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE602005016648T 2004-01-08 2005-01-10 Metallkomplexe mit vitamin b12 als ligand Active DE602005016648D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04075003 2004-01-08
EP04077937 2004-10-25
PCT/EP2005/000168 WO2005068483A1 (en) 2004-01-08 2005-01-10 Metal complexes having vitamin b12 as a ligand

Publications (1)

Publication Number Publication Date
DE602005016648D1 true DE602005016648D1 (de) 2009-10-29

Family

ID=34796701

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005016648T Active DE602005016648D1 (de) 2004-01-08 2005-01-10 Metallkomplexe mit vitamin b12 als ligand

Country Status (12)

Country Link
US (1) US7692002B2 (de)
EP (1) EP1704157B1 (de)
JP (1) JP2007518727A (de)
KR (1) KR20070010119A (de)
AT (1) ATE443070T1 (de)
AU (1) AU2005205126A1 (de)
BR (1) BRPI0506740A (de)
CA (1) CA2552916C (de)
DE (1) DE602005016648D1 (de)
ES (1) ES2334923T3 (de)
IL (1) IL176664A (de)
WO (1) WO2005068483A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101019555B (zh) * 2007-03-23 2011-03-30 南京师范大学 稀土-氨基酸-维生素三元配合物植物生长调节剂及其制备方法
JP5919202B2 (ja) * 2010-03-08 2016-05-18 ユニバーシティー オブ チューリッヒ 医療用一酸化炭素放出レニウム化合物
PL2635583T3 (pl) 2010-11-02 2015-11-30 Promega Corp Pochodne koelenterazyny i metody ich wykorzystania
JP5889910B2 (ja) 2010-11-02 2016-03-22 プロメガ コーポレイションＰｒｏｍｅｇａ Ｃｏｒｐｏｒａｔｉｏｎ 新規セレンテラジン基質及び使用法
US9385033B2 (en) * 2013-09-27 2016-07-05 Intel Corporation Method of forming a metal from a cobalt metal precursor
EP3099683B1 (de) 2014-01-29 2020-08-05 Promega Corporation Chinonmaskierte sonden als markierungsreagenzien für zellaufnahmemessungen
WO2015116806A1 (en) 2014-01-29 2015-08-06 Promega Corporation Pro-substrates for live cell applications

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4560782A (en) * 1982-11-19 1985-12-24 Research Corporation Anti-tumor diplatinum coordination compounds
US4673631A (en) * 1984-12-15 1987-06-16 Canon Kabushiki Kaisha Toner, charge-imparting material and composition containing metal complex
AU3552189A (en) * 1988-05-09 1989-11-29 Public Health Laboratory Service Board, The Use of metal chelate complexes in dehalogenation
US5393909A (en) * 1988-11-22 1995-02-28 Board Of Regents, The University Of Texas System Diamine platinum complexes as antitumor agents
GB8910760D0 (en) * 1989-05-10 1989-06-28 Health Lab Service Board Corrin mediated degradation of organic nitrogen compounds
DE19712388A1 (de) * 1997-03-25 1998-10-01 Studiengesellschaft Kohle Mbh Verfahren zur Synthese von aromatisch substituierten Olefinen
US6844425B1 (en) * 1999-02-24 2005-01-18 Mallinckrodt Inc. Combination of intercalating organometallic complexes and tumor seeking biomolecules for DNA cleavage and radiotherapy
US6797521B2 (en) 1999-10-26 2004-09-28 University Of Utah Research Foundation Fluorescent cobalamins and uses thereof
US6180085B1 (en) 2000-01-18 2001-01-30 Mallinckrodt Inc. Dyes
US6180087B1 (en) 2000-01-18 2001-01-30 Mallinckrodt Inc. Tunable indocyanine dyes for biomedical applications
EP1364652B1 (de) * 2001-01-30 2014-04-09 Dainippon Sumitomo Pharma Co., Ltd. Heilmittel gegen lungenkrebs
ATE424222T1 (de) * 2002-09-03 2009-03-15 Univ Zuerich Herstellung von m(co)3-komplexen durch festphasentechniken durch metal-unterstützte trennung vom festen träger

Also Published As

Publication number Publication date
ES2334923T3 (es) 2010-03-17
US20090175775A1 (en) 2009-07-09
IL176664A0 (en) 2006-10-31
CA2552916C (en) 2014-11-18
BRPI0506740A (pt) 2007-05-15
IL176664A (en) 2013-05-30
KR20070010119A (ko) 2007-01-22
AU2005205126A1 (en) 2005-07-28
WO2005068483A1 (en) 2005-07-28
JP2007518727A (ja) 2007-07-12
EP1704157A1 (de) 2006-09-27
US7692002B2 (en) 2010-04-06
CA2552916A1 (en) 2005-07-28
ATE443070T1 (de) 2009-10-15
EP1704157B1 (de) 2009-09-16

Similar Documents

Publication Publication Date Title
ATE443070T1 (de) Metallkomplexe mit vitamin b12 als ligand
Zayed et al. Synthesis of novel Schiff’s bases of highly potential biological activities and their structure investigation
Casas et al. A gold (I) complex with a vitamin K3 derivative: characterization and antitumoral activity
MX2008011107A (es) Catalizadores de metal de transicion fluorados y formacion de los mismos.
TW200633976A (en) Organic silver complexes, their preparation methods and their methods for forming thin layers
TW200716518A (en) Acetylene derivatives
Zayed et al. Preparation and structure investigation of novel Schiff bases using spectroscopic, thermal analyses and molecular orbital calculations and studying their biological activities
DK1561754T3 (da) Fremgangsmåde til fremstilling af 1,2-diaminocyclohexanplatin(II)-komplekser
DK1404377T3 (da) Forbedrede chelatorkonjugater
Parmar et al. Iron catalysed cross-couplings of azetidines–application to the formal synthesis of a pharmacologically active molecule
ATE311186T1 (de) Verwendung von vitamin pp verbindungen
WO2005001415A3 (en) Optically pure and enriched isomers of chelating ligands and contrast agents
TW200740835A (en) Transition metal complexes and preparation methods thereof
IL174642A0 (en) A process for the preparation of adapalene
TW200728315A (en) Phosphorus transition-metal complex, method of producing the same, and anticancer agent forming the same
ATE471331T1 (de) Neue übergangsmetall-komplexe und deren einsatz in übergangsmetall-katalysierten reaktionen
ATE530557T1 (de) Diphosphinliganden
ATE401329T1 (de) Neue antivirale makrocyclische derivate und metallkomplexe, in die verbrückte makrocyclen eingebaut sind
ATE276259T1 (de) Dihydroporphyrinderivate und ihre verwendung
NO20055334L (no) Bifunksjonelle tridentate pyrazolylinneholdende ligander for RE og TC trikarbonylkomplekser
TW200730473A (en) Process for the production of biphenyls
ATE471513T1 (de) Neue chemilumineszenzverbindungen und ihre verwendung
Benniston et al. The synthesis of small azamacrocycles bearing pendant aromatic functionalities.: The crystal structures of [Cu (L1) 2](PF6) 2,[(L1) CuCl2],[Cu (L6)(NO3) 2] and [Cu2 (L7 H) 2 (OH2) 2](PF6) 2· 3H2O (L1= N-(mesitylethyl)-1, 4, 7-triazacyclononane, L6= N-(4-hydroxymethylbenzyl)-1, 4, 7-triazacylcononane, L7= N-(4-benzylcarboxylic acid)-1, 4, 7-triazacylcononane)
Pershin et al. TRANSITION METAL-FREE C–H-AZOLATION OF PHENANTHRIDINE IN THE LIGAND SYNTHESIS
EP1691847A4 (de) Tame-basierte chelatoren und ihre anwendungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition